Literature DB >> 10493630

Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the pre-operative detection of multifocal breast cancer.

P J Drew1, S Chatterjee, L W Turnbull, J Read, P J Carleton, J N Fox, J R Monson, M J Kerin.   

Abstract

BACKGROUND: Inadequately treated multifocal and multicentric disease results in increased local recurrence following breast-conserving surgery. The accurate preoperative diagnosis of multifocal/ centric breast cancer would facilitate the planning of appropriate surgery and prevent reoperation for residual disease. While triple assessment remains the established diagnostic technique, its sensitivity for the diagnosis of multifocal disease remains poor. Dynamic contrast enhanced Magnetic Resonance Imaging (DCE-MRI) of the breast represents an alternative emerging diagnostic modality that has been shown to be highly sensitive for the delineation of primary breast cancer. The aim of this study was to prospectively compare the diagnostic accuracy of DCE-MRI of the breast with conventional triple assessment for the preoperative diagnosis of multifocal/centric breast cancer.
METHODS: Patients were recruited from the symptomatic breast clinics. All patients underwent standard triple assessment and DCE-MRI. The MRI scans were reported by a single radiologist blinded to the results of the triple assessment. Surgery was then planned accordingly to all available scan results and the specimens examined by a single pathologist. All patients who did not undergo surgery have been followed up for a minimum of 18 months.
RESULTS: A total of 334 women were recruited. There were 178 (52%) cancers that were histologically confirmed and multifocal/centric breast cancer was diagnosed provisionally by the preoperative investigations in 68 (38%); multifocal n = 33, multicentric n = 35, of these patients. In this group, subsequent histology confirmed multifocal/centric disease in 50 (73.5%): multifocal n = 15, multicentric n = 35. Unifocal cancer was found in 15 (22%) and benign disease in 3 (4.4%). The resultant sensitivity, specificity, positive, and negative predictive values were 18%, 100%, 100%, and 76% for triple assessment and 100%, 86%, 73%, and 100% for DCE-MRI.
CONCLUSION: DCE-MRI identified a subgroup of breast cancer patients with multifocal/centric disease not evident on standard triple assessment. MRI of the breast should be considered for the preoperative planning of surgery for primary breast cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10493630     DOI: 10.1007/s10434-999-0599-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  21 in total

1.  Kinetic analysis of lesions without mass effect on breast MRI using manual and computer-assisted methods.

Authors:  Tibor Vag; Pascal A T Baltzer; Matthias Dietzel; Ramy Zoubi; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Eur Radiol       Date:  2010-11-10       Impact factor: 5.315

2.  Contrast-enhanced MRI in breast cancer patients eligible for breast-conserving therapy: complementary value for subgroups of patients.

Authors:  Eline E Deurloo; William F A Klein Zeggelink; H Jelle Teertstra; Johannes L Peterse; Emiel J Th Rutgers; Sara H Muller; Harry Bartelink; Kenneth G A Gilhuijs
Journal:  Eur Radiol       Date:  2005-11-19       Impact factor: 5.315

Review 3.  Technical aspects of breast MRI--do they affect outcomes?

Authors:  Ruth Warren; Stefano Ciatto; Petra Macaskill; Richard Black; Nehmat Houssami
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

4.  Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.

Authors:  Chau Hung Lee; Balamurugan Vellayappan; Matthias Taupitz; Bernd Hamm; Patrick Asbach
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

5.  3.0 Tesla vs 1.5 Tesla breast magnetic resonance imaging in newly diagnosed breast cancer patients.

Authors:  Reni S Butler; Christine Chen; Reena Vashi; Regina J Hooley; Liane E Philpotts
Journal:  World J Radiol       Date:  2013-08-28

6.  Discrimination of benign and malignant breast lesions by using shutter-speed dynamic contrast-enhanced MR imaging.

Authors:  Wei Huang; Luminita A Tudorica; Xin Li; Sunitha B Thakur; Yiyi Chen; Elizabeth A Morris; Ian J Tagge; Maayan E Korenblit; William D Rooney; Jason A Koutcher; Charles S Springer
Journal:  Radiology       Date:  2011-08-09       Impact factor: 11.105

7.  Computer-aided interpretation of dynamic magnetic resonance imaging reflects histopathology of invasive breast cancer.

Authors:  Pascal A T Baltzer; Tibor Vag; Matthias Dietzel; Sebastian Beger; Christian Freiberg; Mieczyslaw Gajda; Oumar Camara; Werner A Kaiser
Journal:  Eur Radiol       Date:  2010-03-04       Impact factor: 5.315

Review 8.  Magnetic resonance imaging in the preoperative assessment of patients with primary breast cancer: systematic review of diagnostic accuracy and meta-analysis.

Authors:  María Nieves Plana; Carmen Carreira; Alfonso Muriel; Miguel Chiva; Víctor Abraira; Jose Ignacio Emparanza; Xavier Bonfill; Javier Zamora
Journal:  Eur Radiol       Date:  2011-08-17       Impact factor: 5.315

9.  Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection.

Authors:  H Kim; H H Kim; J S Park; H J Shin; J H Cha; E Y Chae; W J Choi
Journal:  Br J Radiol       Date:  2014-08-27       Impact factor: 3.039

10.  Role of diffusion MRI in characterizing benign and malignant breast lesions.

Authors:  Lalitha Palle; Balaji Reddy
Journal:  Indian J Radiol Imaging       Date:  2009 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.